Table 2.
Clinical Details Relating to Patient Samples
| Log-rank (Mantel-Cox)* | ||
|---|---|---|
| T stage | ||
| T1 | 8 | 0.259 |
| T2 | 15 | |
| T3 | 28 | |
| N stage | ||
| N0 | 21 | 0.676 |
| N1 | 30 | |
| Differentiation | ||
| Well | 6 | 0.062 |
| Moderate | 26 | |
| Poor | 19 | |
| Venous and Neural | ||
| Nil | 4 | 0.936 |
| Venous | 15 | |
| Neural | 13 | |
| Both | 19 | |
| Resection margin | ||
| Negative | 18 | 0.045 |
| Positive | 33 | |
| Chemoradiotherapy | ||
| None | 11 | 0.807 |
| Chemotherapy | 22 | |
| Radiotherapy | 8 | |
| Both | 10 |
*
Comparison of Kaplan-Meier survival curves across sub-groups for each variable known to affect survival of patients with pancreatic ductal adenocarcinoma.